"Scott Pelley: Is there a bad guy in this equation? Employers who won't pay, #drugcompanies that are charging enormous fees for these #drugs?
Jonathan Gruber: The manufacturer is not the bad guy. The company's not the bad guy. Really, there's no bad guys here Scott. We just have to recognize as society that something's changed. We have a new miraculous and expensive mode of treatment, and we society need to recognize that we need to act jointly to absorb those costs."
Breakthrough genetic therapies can save lives, but many cost millions for single dose
A new class of life-saving drugs is helping children who once had no hope. But some carry a price tag of millions for a single dose, and the American healthcare system hasn't figured out how to pay.


